Universal Detection Technology, developers of air monitoring devices, bioterrorism detection devices and other early-warning monitoring systems, recently issued a press release addressing the growing concern to immunize first responders in the case of anthrax exposure. This question was brought forth at the annual EMS Today Conference in Baltimore. The conference was held over March 1 through March 5.

Jacques Tizabi, CEO of Universal Detection Technology was quoted as saying, “Immunizing first responders goes hand-in-hand with giving them the necessary tools and training to rapidly detect on-site the presence of anthrax or other deadly bioagents and respond appropriatelyā€¯. Universal Detection Technologies has developed products that accurately detect the presence of anthrax spores and other deadly bioagents in as little as 3 minutes, helping to ensure safety and proper treatment to medical responders in a timely manner. Any delays in detection and appropriate initiation of chemoprophylaxis can result in many more deaths and millions of dollars in treatments.

UNDT now has 5 different detection kits that are being used throughout the United States by first responders and private industries. The US Department of Defense and the United Kingdom military have run tests on these kits and found that they do not produce false positives or display cross-reactivity with near-neighbor species. These kits have been developed to test for anthrax, botulinum toxin, ricin, plague (Y. Pestis) and SEBs.

UNDT also offers training material and other real-time air monitoring systems to detect other forms of air pollution, included acid rain, smog, and ozone depletion. There flagship product, the BSM-2000, is an automated, unattended, real-time air monitoring system with alert capabilities. The company is based in Beverly Hills, CA.